ОБЗОР2025 · pp. 3–15
Seliverstov P.V., Ananyan M.A., Marchenko S.D., Stepanov M.R., Voznesenskaya E.A., Ilina K.V., Lyapustin K.Yu.
Introduction. Nanotechnology represents an innovative direction in cancer drug development, enabling the creation of effective drug delivery systems with enhanced therapeutic properties. Objective. To analyze the main types of nanoparticles used in oncology, e…
ОБЗОР2023 · pp. 3–11
Morozova O.V.
Introduction. Entry of inorganic and organic nanomaterials through respiratory tract, skin and digestive system increases the risks of immunological disorders, hereditary and oncological diseases. Localization and stability of nanoparticles are determined by t…
Research article2012
Demin V.F., Belushkina N.N., Paltsev M.A.
An approach to the development of methodology for health risk assessment (HRA) for the effects of new environmental factors: nanoparticles and nanobiomaterials (NP/NBM) – products of modern nano-, nanobiotechnology has been proposed. The experience from develo…